By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioInvent 

Ideon Science and Technology Park
Sölvegatan 41
Lund    S-223 70  Sweden
Phone: 46-46-286-8550 Fax: 46-46-211-0806


SEARCH JOBS


Industry
Pharmaceutical

Segment
Drug Discovery





Company News
FDA Slaps a Full Clinical Hold on BioInvent (BOVNF)'s Phase II Multiple Myeloma Study 11/8/2016 5:23:51 AM
BioInvent (BOVNF) Interim Report 1 January – 30 September 2016 10/25/2016 10:49:53 AM
BioInvent (BOVNF) Interim Report: 1 January – 30 September 2016 10/25/2016 9:11:25 AM
BioInvent (BOVNF) Expands Patent Approvals For Its Lead Clinical Immuno-Oncology Programme In Multiple Myeloma, BI-505 9/19/2016 8:22:49 AM
BioInvent (BOVNF) Extends Manufacturing Services Contract With Major Global Pharmaceutical Client; Expects To Generate Approximately SEK 8 Million In Revenue 8/29/2016 11:31:17 AM
BioInvent (BOVNF) Interim Report 1 January – 30 June 2016 7/26/2016 10:55:15 AM
BioInvent (BOVNF) Enter Process Development And Manufacturing Collaboration With Alligator 7/8/2016 11:03:08 AM
BioInvent (BOVNF): Resolution At BioInvent’s Annual General Meeting 2016 5/13/2016 9:36:59 AM
BioInvent (BOVNF)’s Board Director Dharminder Chahal Increases His Shareholding In The Company 5/6/2016 9:27:44 AM
BioInvent (BOVNF), Oncurious And NMTRC Initiating Phase I/IIa Study With TB-403 For The Treatment Of Medulloblastoma 5/2/2016 8:56:46 AM
12345678910...
//-->